Build vs Buy: Should Your Lab Build PGx Reporting In-House?

How Clinical Labs Launch a Pharmacogenomics Reporting Service

CPIC, FDA & DPWG: Which Guidelines Should PGx Reports Follow?

Delivering PGx Results into the EHR with FHIR & CDS Hooks

What Makes a Pharmacogenomic Report Clinically Defensible?

Living Reports: Keeping Pharmacogenomic Guidance Current

White-Labeling PGx Reports Under Your Lab's Brand

From Genotype to Guidance: Inside the PGx Reporting Pipeline

Scaling a PGx Reporting Line Without Adding Headcount

Turning Fragmented Evidence into One Source of PGx Truth

Why Most Lab PGx Programs Stall — and How to Launch Faster